Protein-based therapies promise to treat everything from cancer to arthritis, but the bacteria and mammalian cells that usually produce proteins leave much to be desired. New research shows that green algae—and genetically tweaked yeast—can churn out proteins that are cheaper and better tailored for human use than those made by traditional systems. Amber Dance reports on these new recruits in the pharma factory.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dance, A. From pond scum to pharmacy shelf. Nat Med 16, 146–149 (2010). https://doi.org/10.1038/nm0210-146
Issue Date:
DOI: https://doi.org/10.1038/nm0210-146
This article is cited by
-
Drugmaker reaps what it sows with first plant-made biologic
Nature Medicine (2012)
-
Emerging biomedical applications of synthetic biology
Nature Reviews Genetics (2012)